Key facts
- Boehringer Ingelheim Venture Fund is a other based in Ingelheim am Rhein, Germany with 21 tracked portfolio companies.
- Notable positions include AgomAb, Rgenta Therapeutics, Wellth (Healthcare Technology Systems), Brainomix, PulseSight Therapeutics.
About Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund is a direct investment firm based in Ingelheim am Rhein, Germany. Established in 2010, it is the strategic venture fund of the Boehringer Ingelheim Corporation. It invests in pioneering science that offers the potential to provide a significant benefit for patients. It operates as a subsidiary under Boehringer Ingelheim. The assets of the firm are managed by its executive management team.
Free account
See the whole book
- ·The book's top 25 — of 21 recorded positions
- ·Watchlist + alerts for Boehringer Ingelheim Venture Fund's activity
Create free account
No card required
Portfolio, priced
21 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| AgomAb | Drug Discovery | $415.6M | — | |
| Rgenta Therapeutics | — | $119.0M | — | |
| Wellth (Healthcare Technology Systems) | — | $75.0M | — | |
| Brainomix | — | $71.3M | — | |
| PulseSight Therapeutics | — | $64.5M | — | |
| HepaRegenix | — | $43.2M | — | |
| xCures | Medical Records Systems | $34.8M | — | |
| Nuevocor | — | $30.1M | — | |
| STRM.BIO | — | $26.0M | — | |
| Diogenx | — | $21.2M | — | |
| Centauri Therapeutics | — | $15.8M | — | |
| Obulytix | — | $8.1M | — | |
| Tecregen | — | $7.5M | — | |
| EvlaBio | — | $800K | — | |
| Tacalyx | — | — | — | |
| + 6 more companies · a free account shows the top of the book | ||||
Frequently asked
- What companies does Boehringer Ingelheim Venture Fund invest in?
- Boehringer Ingelheim Venture Fund has 21 recorded portfolio companies, including AgomAb, Rgenta Therapeutics, Wellth (Healthcare Technology Systems), Brainomix.
- What is Boehringer Ingelheim Venture Fund's AUM?
- Boehringer Ingelheim Venture Fund manages approximately $405 in assets.